• 1. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 2. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
• 3. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367
• 4. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 5. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053

Introduction to 2-(4-Methylphenyl)-1H-indole (CAS No. 55577-25-8)

2-(4-Methylphenyl)-1H-indole, identified by its Chemical Abstracts Service (CAS) number 55577-25-8, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound belongs to the indole family, characterized by a bicyclic structure consisting of a benzene ring fused to a pyrrole ring. The presence of a methyl substituent at the para position of the phenyl ring introduces unique electronic and steric properties, making it a valuable scaffold for medicinal chemistry applications.

The molecular structure of 2-(4-Methylphenyl)-1H-indole consists of a central indole core, which is a well-known motif in natural products and bioactive molecules. The indole scaffold is particularly relevant in medicinal chemistry due to its prevalence in biologically active compounds, including several FDA-approved drugs. The introduction of the 4-methylphenyl group at the C2 position of the indole ring enhances its potential as a pharmacophore, influencing both its solubility and binding affinity to biological targets.

In recent years, 2-(4-Methylphenyl)-1H-indole has been explored as a key intermediate in the synthesis of various pharmacologically active agents. Its structural features make it an attractive candidate for further derivatization, allowing researchers to modulate its properties for specific therapeutic applications. For instance, derivatives of this compound have shown promise in the development of compounds with antimicrobial, anti-inflammatory, and even anticancer properties.

One of the most compelling aspects of 2-(4-Methylphenyl)-1H-indole is its role in the synthesis of small-molecule inhibitors targeting enzymes involved in critical biological pathways. The indole moiety is particularly adept at interacting with aromatic residues in protein active sites, making it an effective tool for designing molecules that can modulate enzyme activity. This has led to several studies investigating its potential as a lead compound for drug discovery programs targeting diseases such as cancer and neurodegenerative disorders.

Recent advancements in computational chemistry have further enhanced the utility of 2-(4-Methylphenyl)-1H-indole as a building block for drug design. Molecular modeling studies have demonstrated that modifications to the indole core, such as the introduction of additional functional groups or ring substitutions, can significantly alter the binding affinity and selectivity of derived compounds. These insights have guided synthetic efforts toward optimizing lead structures for improved pharmacological profiles.

The synthesis of 2-(4-Methylphenyl)-1H-indole typically involves multi-step organic reactions, often starting from readily available precursors like 4-methylbenzaldehyde and tryptophan derivatives. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making this compound more accessible for industrial applications. Techniques such as palladium-catalyzed cross-coupling reactions have been particularly useful in constructing the indole core with high precision and yield.

From a biological perspective, 2-(4-Methylphenyl)-1H-indole has been investigated for its potential interactions with various biological targets. Initial studies have suggested that derivatives of this compound may exhibit inhibitory effects on enzymes such as cyclooxygenase-2 (COX-2), which is implicated in inflammation and pain pathways. Additionally, modifications to the indole scaffold have been explored to enhance binding to receptors involved in neurotransmitter signaling, opening avenues for applications in central nervous system disorders.

The versatility of 2-(4-Methylphenyl)-1H-indole as a chemical scaffold is further highlighted by its use in combinatorial chemistry libraries. By systematically varying substituents on the indole ring, researchers can generate diverse sets of compounds for high-throughput screening campaigns. This approach has been instrumental in identifying novel bioactive molecules with therapeutic potential across multiple disease areas.

In conclusion, 2-(4-Methylphenyl)-1H-indole (CAS No. 55577-25-8) represents a promising compound in pharmaceutical research due to its unique structural features and biological relevance. Its role as an intermediate in drug development, coupled with advancements in synthetic and computational chemistry, positions it as a valuable asset for future therapeutic innovations. As research continues to uncover new applications for this compound, it is likely to remain a cornerstone in medicinal chemistry endeavors aimed at addressing unmet medical needs.

• 23746-81-8(2-(2-Naphthyl)indole)
• 19714-27-3(1H-Benz[g]indole, 2-(4-methylphenyl)-)
• 21470-37-1(2-Biphenyl-4-yl-1H-indole)
• 19714-26-2(3H-Benz[e]indole, 2-(4-methylphenyl)-)
• 106012-31-1(Pyrrolo[3,2-a]carbazole, 3,10-dihydro-2-phenyl-)
• 33555-17-8(1H-Benz[g]indole, 2-phenyl-)
• 948-65-2(2-phenyl-1H-indole)
• 13228-36-9(5-Methyl-2-phenylindole)
• 38829-78-6(2-phenyl-3H-benzo[e]indole)
• 38824-47-4(2-phenyl-1H-benzo[f]indole)